Skip to content
Back To Our Shop

Adalimumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response.

Category:

Key Advantages

Supports the investigation of primary non-response and loss of response to adalimumab

Highly sensitive assay that only detects free anti-adalimumab antibodies

May help predict long term outcome of disease

Applicable to both gastroenterology and rheumatology

Automatable on ELISA automates (e.g. Dynex DS2)

Determination of free anti-adalimumab antibodies

Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Adalimumab Free Anti-drug ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free anti-adalimumab antibodies in plasma or serum samples. Detecting high levels of free anti-adalimumab antibodies in patients when the drug level is low (undetectable or sub-therapeutic) may indicate poorer long-term outcomes and suggest the need to switch treatment.

Please contact us for your nearest test reference laboratory.

  • ELISA

  • 45 tests

  • Storage: 2-8 °C

  • Blood sample